| Serial Number | 79327240 |
| Word Mark | ARECOR |
| Filing Date | Tuesday, September 28, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 23, 2024 |
| Registration Number | 7361956 |
| Registration Date | Tuesday, April 23, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 6, 2024 |
| Goods and Services | Medical preparations, namely, diagnostic preparations for medical purposes, preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Medicinal products, namely, pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Pharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Biopharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infectives, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders |
| Goods and Services | Medical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Arecor Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Arecor Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Arecor Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Tuesday, December 7, 2021 | APPLICATION FILING RECEIPT MAILED |
| Thursday, December 2, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 28, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, June 29, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, June 30, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 28, 2022 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Thursday, August 4, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, October 3, 2022 | REFUSAL PROCESSED BY IB |
| Friday, August 5, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 13, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 14, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, March 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 16, 2023 | SUSPENSION LETTER WRITTEN |
| Thursday, March 16, 2023 | LETTER OF SUSPENSION E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 3, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, May 3, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, May 22, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, June 20, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, November 22, 2023 | ASSIGNED TO LIE |
| Wednesday, November 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 17, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 17, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Thursday, January 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, February 5, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 23, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, July 24, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |